Literature DB >> 2357964

The beta-globin dominant control region: hypersensitive site 2.

S Philipsen1, D Talbot, P Fraser, F Grosveld.   

Abstract

The Dominant Control Region (DCR) of the human beta-globin gene locus consists of four strong hypersensitive sites (HSS) upstream of the epsilon-globin gene. Addition of these sites confers copy number dependent expression on the human beta-globin gene in murine erythroleukaemia cells and transgenic mice, at levels comparable with the endogenous mouse globin genes. We have shown previously that a 1.9 kb fragment comprising HSS 2 accounts for 40-50% of the full effect of the DCR. In this paper we describe a deletional analysis of HSS 2. We show that a 225 bp fragment is sufficient to direct high levels of expression of the human beta-globin gene which is copy number dependent and integration site independent. This 225 bp fragment overlaps the major region that is hypersensitive 'in vivo'. DNase I footprinting shows the presence of four binding sites for the erythroid specific protein NF-E1; the three other footprinted regions display a remarkable redundancy of the sequence GGTGG and bind a number of proteins including Sp1 and the CACC box protein. The significance of these results for the regulation of globin gene expression is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357964      PMCID: PMC551938          DOI: 10.1002/j.1460-2075.1990.tb07385.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  39 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions.

Authors:  D Gidoni; J T Kadonaga; H Barrera-Saldaña; K Takahashi; P Chambon; R Tjian
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

3.  The "beta-like-globin" gene domain in human erythroid cells.

Authors:  D Tuan; W Solomon; Q Li; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 5.  The molecular genetics of human hemoglobin.

Authors:  F S Collins; S M Weissman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1984

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Developmental regulation of a cloned adult beta-globin gene in transgenic mice.

Authors:  J Magram; K Chada; F Costantini
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

8.  An embryonic pattern of expression of a human fetal globin gene in transgenic mice.

Authors:  K Chada; J Magram; F Costantini
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  Detailed analysis of the site 3 region of the human beta-globin dominant control region.

Authors:  D Talbot; S Philipsen; P Fraser; F Grosveld
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  101 in total

1.  Enhancement of beta-globin locus control region-mediated transactivation by mitogen-activated protein kinases through stochastic and graded mechanisms.

Authors:  E C Forsberg; T N Zaboikina; W K Versaw; N G Ahn; E H Bresnick
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  The polyoma virus enhancer cannot substitute for DNase I core hypersensitive sites 2-4 in the human beta-globin LCR.

Authors:  K Tanimoto; Q Liu; J Bungert; J D Engel
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

3.  Beta-globin locus activation regions: conservation of organization, structure, and function.

Authors:  Q L Li; B Zhou; P Powers; T Enver; G Stamatoyannopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 4.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

5.  Characterization of the factors binding to a PEPCK gene upstream hypersensitive site with LCR activity.

Authors:  T E Cheyette; T Ip; S Faber; Y Matsui; R Chalkley
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

6.  Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression.

Authors:  C Kingsley; A Winoto
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

7.  Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements.

Authors:  M Walters; D I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Multiple interactions between regulatory regions are required to stabilize an active chromatin hub.

Authors:  George P Patrinos; Mariken de Krom; Ernie de Boer; An Langeveld; A M Ali Imam; John Strouboulis; Wouter de Laat; Frank G Grosveld
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

9.  Regulated expression of the human beta globin gene in transgenic mice requires an upstream globin or nonglobin promoter.

Authors:  K P Anderson; J A Lloyd; E Ponce; S C Crable; J C Neumann; J B Lingrel
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

10.  A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins.

Authors:  I J Miller; J J Bieker
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.